These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 504963)

  • 1. Glucagon secretion in subjects with prediabetes, diabetes mellitus and obesity.
    Slavnov VN; Epshtein EV; Efimov AS; Malinkovich VD; Stepanenko LI
    Endocrinologie; 1979; 17(3):213-8. PubMed ID: 504963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon.
    Lefebvre PJ; Luyckx AS; Lecomte MJ
    Horm Metab Res; 1976; Suppl 6():91-8. PubMed ID: 1278843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.
    Kyner JL; Levy RI; Soeldner JS; Gleason RE; Fredrickson DS
    J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma levels of beta-endorphin in obese subjects with normal glucose tolerance test and in diabetics].
    Donatelli M; Terrizzi C; Russo V; Bucalo ML; Scarpinato A; Verga S; Puglisi S; Miceli G; Iraci T; Bompiani GD
    Recenti Prog Med; 1991 Jan; 82(1):1-3. PubMed ID: 2028070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of insulin sensitivity in early diabetes. II. Insulin resistance in asymptomatic diabetics.
    Schulz B; Ratzmann KP; Witt S; Anders M; Ehrlich M
    Endokrinologie; 1980 Jul; 76(1):103-11. PubMed ID: 7002536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucagon secretion in several endocrine diseases].
    Slavnov VN; Epshteĭn EV; Malinkovich VD; Stepanenko LI
    Probl Endokrinol (Mosk); 1978; 24(6):35-9. PubMed ID: 364465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of prediabetes.
    Bhansali A; Dutta P
    J Indian Med Assoc; 2005 Nov; 103(11):594-5, 599. PubMed ID: 16570762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum prolactin in obese subjects with and without glucose intolerance].
    Smedile G; Pata P; Mancuso TR; Morabito S; Forgione F
    Boll Soc Ital Biol Sper; 1981 Mar; 57(5):518-21. PubMed ID: 7020720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects.
    Wise JK; Hendler R; Felig P
    N Engl J Med; 1973 Mar; 288(10):487-90. PubMed ID: 4567490
    [No Abstract]   [Full Text] [Related]  

  • 15. Exaggerated glucagon secretion in diabetic and non-diabetic subjects with surgical porto-caval anastomosis.
    Fallucca F; Ziparo V; Giangrande L; Menzinger G; Stipa S
    Horm Metab Res; 1981 Oct; 13(10):545-7. PubMed ID: 7298009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal glucagon response to arginine infusion in "prediabetic" Pima Indians.
    Aronoff SL; Bennett PH; Rushforth NB; Miller M; Unger RH
    J Clin Endocrinol Metab; 1976 Aug; 43(2):279-86. PubMed ID: 950363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, growth hormone, and glucagon in prediabetes mellitus--a review.
    Johansen K; Soeldner JS; Gleason RE
    Metabolism; 1974 Dec; 23(12):1185-99. PubMed ID: 4610319
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vascular alterations and GH secretion in latent chemical diabetes].
    Sgambato S; Carbone L; Bisesti V; Passariello N; Tesauro P; Varano R
    Boll Soc Ital Biol Sper; 1979 Feb; 55(3):279-85. PubMed ID: 399851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of growth hormone and glucagon in diabetic patients and relatives of diabetic patients.
    Knopf RF; Fajans SS; Pek S; Floyd JC; Prchkov VK; Conn JW
    Adv Metab Disord; 1973; 2():Suppl 2:215-25. PubMed ID: 4720363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.